More Information on 'PROGEN Biotechnik GmbH'

PROGEN is a biotechnology company that specializes in developing and manufacturing analytical tools and antibodies for gene therapy, particularly for adeno-associated virus (AAV) vectors. The company's core products include ELISA kits, antibodies, and lateral flow tests, such as the AAV Dip'n'Check, which enable researchers and manufacturers to detect, quantify, and characterize AAV vectors. PROGEN's tools are designed to support the development and production of gene therapies, helping to ensure their safety, efficacy, and quality. With a focus on reliability, ease of use, and affordability, PROGEN's products are used by researchers and manufacturers in academia and industry to accelerate the development of new gene therapies.

About PROGEN Biotechnik GmbH
PROGEN was founded in 1983 by four scientists from Heidelberg, Germany, who joined forces to manufacture and supply high quality antibodies for biomedical research. We help scientists worldwide drive biopharmaceutical and diagnostic progress to provide high-quality and reliable treatments for patients. Our mission is to make new therapies safe and affordable and to improve existing research processes. The PROGEN team consists of bioscientists and adeno-associated virus (AAV) experts who collaborate with specialists around the world. Our products are essentials for research in science and industry. We are more than just a manufacturer of antibodies, AAV gene therapy tools, density gradient media, and phage display technologies: We strive to understand the needs of scientists to develop solutions to jointly address challenges in academic research, biotechnology and pharma. Since October 2012 Progen is a 100% subsidiary of the R-Biopharm AG. Together with the R-Biopharm Group Progen will further develop its product range in order to meet market needs and strengthen its core competence in the field of life science reagents.